11-2885400-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001122630.2(CDKN1C):c.57C>A(p.Cys19*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C19C) has been classified as Likely benign.
Frequency
Consequence
NM_001122630.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Beckwith-Wiedemann syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- IMAGe syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, G2P, Ambry Genetics
- rhabdomyosarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- Beckwith-Wiedemann syndrome due to CDKN1C mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- intrauterine growth restriction-short stature-early adult-onset diabetes syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Silver-Russell syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001122630.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKN1C | NM_001122630.2 | MANE Select | c.57C>A | p.Cys19* | stop_gained | Exon 2 of 4 | NP_001116102.1 | ||
| CDKN1C | NM_000076.2 | c.90C>A | p.Cys30* | stop_gained | Exon 1 of 3 | NP_000067.1 | |||
| CDKN1C | NM_001362474.2 | c.90C>A | p.Cys30* | stop_gained | Exon 1 of 3 | NP_001349403.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKN1C | ENST00000440480.8 | TSL:1 MANE Select | c.57C>A | p.Cys19* | stop_gained | Exon 2 of 4 | ENSP00000411257.2 | ||
| CDKN1C | ENST00000414822.8 | TSL:1 | c.90C>A | p.Cys30* | stop_gained | Exon 1 of 3 | ENSP00000413720.3 | ||
| CDKN1C | ENST00000430149.3 | TSL:1 | c.90C>A | p.Cys30* | stop_gained | Exon 1 of 3 | ENSP00000411552.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1405962Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 695270
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Beckwith-Wiedemann syndrome Pathogenic:2
Absent from controls (or at extremely low frequency if recessive) in Genome Aggregation Database, Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium.;Null variant in a gene where loss of function (LOF) is a known mechanism of disease.
This variant has not been reported in the literature in individuals with CDKN1C-related conditions. This sequence change creates a premature translational stop signal (p.Cys30*) in the CDKN1C gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDKN1C are known to be pathogenic (PMID: 20503313). This variant is not present in population databases (ExAC no frequency). For these reasons, this variant has been classified as Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at